DEVS vs JNJ · rev $25.8K vs P/E 17, rev $49.37B
DevvStream Corp. Common Stock (DEVS) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
DevvStream Corp. Common Stock (DEVS) is a pollution & treatment controls company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported DEVS revenue for 2025-07-31 was $25.8K. Net income was -$12.1M. DEVS currently screens at market cap $13.4M.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
DEVS currently screens at market cap $13.4M. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the DEVS and JNJ stock pages for the full models.
Not investment advice.